Growing Complex Generic Application Load May Force US FDA Staffing Changes
Executive Summary
Complex products are slowly gaining a larger share of ANDA submission and approval totals, which could mean the FDA has to adapt its in-house expertise to compensate.
You may also be interested in...
ANDA Sponsors Given More Paperwork
Optional checklists will help ensure submissions have all the required information.
ANDA Sponsors Given More Paperwork, But New Cover Letter Could Actually Be A Time-Saver
Optional checklists will help ensure submissions have all the required information.
GDUFA III: Convening Enhanced Mid-Cycle Meeting Will Cost Sponsors
Requesting the new meeting type for an ANDA assessment will trigger a goal date extension with another possible should an unsolicited application amendment also be necessary.